News All News

Researchers in Andrew Kruse’s lab overcame a key obstacle in using the hormone relaxin as a therapy for heart disease. With support from Harvard’s Blavatnik Biomedical Accelerator, this discovery led to the launch of Tectonic Therapeutic, which is now testing its relaxin-based drug in clinical trials.

Five companies started with discoveries in Harvard labs and, with various forms of support, developed impactful solutions that are enhancing our quality of life.

Harvard SEAS researchers have created a device that can bridge digital electronic signals and analog light signals in one fluid step, offering a potential replacement for energy-intensive systems used in today’s high-speed data networks. The researchers’ device was fabricated using a lithium niobate foundry process developed by HyperLight Corporation, a startup that is advancing innovations from Prof. Marko Loncar’s lab.

Axoft, a startup launched with technology developed in Harvard labs, is transforming care for traumatic brain injuries with its soft, biocompatible neural probe that can quickly measure recovery and consciousness within a few minutes.